Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis
Chou, Y-Yi.; Lin, T-Yu.; Lin, J-Chung.; Wang, N-Chi.; Peng, M-Yieh.; Chang, F-Yee.
Journal of Microbiology Immunology and Infection 41(2): 124-129
2008
ISSN/ISBN: 1684-1182 PMID: 18473099 Document Number: 616013
Background and Purpose: Vancomycin-resistant enterococci (VRE) have emerged as important nosocomial pathogens. This study was conducted to clarify the clinical features and outcome of patients with vancomycin-resistant enterococcal bacteremia.Methods: Patients with vancomycin-resistant enterococcal bacteremia treated at a medical center in northern Taiwan between November 1998 and July 2006 were reviewed. Clinical and bacteriological characteristics of Enterococcus faecium and Enterococcus faecalis were compared.Results: Twelve patients (6 males and 6 females) were included for analyses. The mean age was 69.3 years (range, 40 to 86 years), and 8 cases (66.7%) were older than 65 years. All patients had underlying disease. Two patients received total hip replacement before development of VRE bacteremia. Twelve patients had prior exposure to broad-spectrum antimicrobial therapy. Ten patients had prior intensive care unit stay and prior mechanical ventilation before VRE bacteremia. All of the patients (n = 12) had an intravascular catheter in place. Bacteremia was caused by E faecalis in 4 patients and by E faecium in eight. The portals of entry included urinary tract (8.3%), skin, soft tissue and bone (41.7%) and unknown sources (50.0%). E faecium showed a higher rate of resistance to ampicillin and teicoplanin than E faecalis (87.5% vs 0.0%, p=0.01). The 60-day mortality rate was higher in patients with E. faecium bacteremia than E faecalis bacteremia (62.5% vs 0.0%), although statistical significance was not obtained (p=0.08).Conclusions: VRE bacteremia may have an impact on the mortality and morbidity of hospitalized patients. Patients with bacteremia caused by vancomycin-resistant E faecium had a grave prognosis, especially immuno-suppressed patients. The prudent use of antibiotics and strict enforcement of infection control may prevent further emergence and spread of VRE.